What a happy Christmas they’ve had at Colorado State University this year. The vet school–and, in fact, the entire university–is celebrating news that philanthropist horse owners John and Leslie Malone have donated $43 million to the university to establish the CSU Institute for Biologic Translational Therapies.
The rest of us can do a little happy dance, too, as the research from the new institute will benefit horses everywhere and is expected to translate to human medicine, as well.
From today’s official announcement:
Colorado philanthropists John and Leslie Malone, fascinated by the healing power of stem cells, have committed a record $42.5 million to Colorado State University to develop regenerative medical therapies for animals and people.
It is the largest cash gift in university history, a remarkable commitment to improved human and animal health and well-being.
The donation will launch the CSU Institute for Biologic Translational Therapies to investigate next-generation remedies based on living cells and their products, including patient-derived stem cells, to treat musculoskeletal disease and other ailments.
Colorado State veterinarians are expert at analyzing medical treatments for animal patients, then providing knowledge gained to boost human medical advancements; the progression is known as translational medicine and is successful because of similarities in animal and human physiology and disease.
“We are tremendously grateful to John and Leslie Malone for their generous philanthropy, foresight and dedication to scientific discovery,” Colorado State President Tony Frank said. “
In addition to being the largest cash gift in the university’s history, their commitment positions us to build on our foundation as a leader in translational medicine, where advances in veterinary medicine very rapidly move into the sphere of benefitting human health.”
The new institute will be unique in its focus on developing regenerative treatments from inception in the laboratory setting, through clinical trials, to commercialization of new technologies.
Malones’ horses help inspire gift
“You put so much training into them, it would be wonderful to have them enjoy their health for a longer period,” Leslie Malone said. She led through her immaculate barn a promising dressage competitor named Blixt, a gelding that suffered lameness, underwent successful arthroscopic surgery at the Colorado State Orthopaedic Research Center, received stem-cell injections, and now is back to training.
“We think this whole area of research is very exciting in what it portends for humans and animals,” John Malone said. “When you say, ‘Who’s in the best position to do something about this?’ – to take cutting-edge research and apply it pragmatically to the problems we see that people and horses are encountering on a day-to-day basis – it became pretty logical. CSU was the right place to go.”
The Malones’ gift will provide $10 million for operations and $32.5 million for construction of an institute building, to feature laboratories, specialized surgical suites, and conference space for veterinarians and physicians. The lead gift requires $32.5 million in matching donations for building construction.
Gift will shape future therapeutics
A syringe of cultured, patient-derived stem cells is ready for injection into a horse’s injured joint to promote healing.
“We are truly appreciative and humbled by John and Leslie Malone’s contribution to Colorado State University. This is a transformational gift that will make a difference in our society today and in the future,” Brett Anderson, vice president for advancement, said.
The Malones, dedicated to dressage and racehorses, first encountered Colorado State through its Orthopaedic Research Center, led by Dr. Wayne McIlwraith, University Distinguished Professor and renowned equine arthroscopic surgeon.
In 2013, the philanthropic couple donated $6 million to endow the Leslie A. Malone Presidential Chair in Equine Sports Medicine, a way to foster prevention, diagnosis and treatment of injuries in performance horses.
They soon focused on the Orthopaedic Research Center’s work in biological therapies – with gene therapy, stem cells, specialized tissue replacement and novel proteins. These therapies, used alone and in combination with minimally invasive surgery, could provide more effective and longer-lasting treatment for equine athletes and people with osteoarthritis and orthopaedic injuries.
“We are so thankful for John and Leslie’s support and consider them real partners,” McIlwraith said.
Veterinary medicine has a unique role
Colorado State has demonstrated the value of treating animal patients with naturally occurring disease as a vital step in developing new treatments for human patients, noted Dr. Mark Stetter, dean of the CSU College of Veterinary Medicine and Biomedical Sciences.
The approach provides a logical and clinically relevant step in the benchtop-to-bedside research path for new therapeutics: Veterinarians design clinical trials to treat animals with chronic or acute illness; knowledge gained in the course of this treatment helps spark new therapies for pets and people.
“We are extremely grateful to Dr. and Mrs. Malone for supporting the unique role of veterinary medicine by so significantly supporting strides in animal medicine that may be translated into new options in human healthcare,” Stetter said.
Biological therapies are the next horizon
John Malone, a dedicated athlete in his school days, described his own orthopaedic aches and pains while explaining the vision he and his wife have for advancing regenerative treatments.
“This is a very exciting and very broad area of research, and it’s going to pay big dividends in both human and animal medicine,” Malone said. “It seems entirely appropriate to assist in the development of this research at one of the top vet schools in the country.”
The institute established with the Malones’ lead gift will allow Colorado State to vault ahead in its work.
“We’ve really gone through a transformation in recent years, with more participation in human medicine,” said McIlwraith, leader of the Orthopaedic Research Center. “This has occurred because of the comparability of equine joints and equine joint problems with human joint problems, extending into tendon and ligament injuries, which are big concerns